These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8631589

  • 1. Can papilloma virus testing be used to improve cervical cancer screening?
    Jenkins D, Sherlaw-Johnson C, Gallivan S.
    Int J Cancer; 1996 Mar 15; 65(6):768-73. PubMed ID: 8631589
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
    Kim JJ, Wright TC, Goldie SJ.
    JAMA; 2002 May 08; 287(18):2382-90. PubMed ID: 11988059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
    Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):765-74. PubMed ID: 16757701
    [Abstract] [Full Text] [Related]

  • 5. Time to consider HPV testing in cervical screening.
    Cuzick J.
    Ann Oncol; 2001 Nov 07; 12(11):1511-4. PubMed ID: 11822748
    [No Abstract] [Full Text] [Related]

  • 6. HPV testing in cervical screening.
    Cuzick J.
    Pharmacoepidemiol Drug Saf; 2001 Nov 07; 10(1):33-6. PubMed ID: 11417064
    [No Abstract] [Full Text] [Related]

  • 7. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 8. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
    Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, New Technologies for Cervical Cancer Screening Working Group.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):492-501. PubMed ID: 18364502
    [Abstract] [Full Text] [Related]

  • 9. HPV testing in primary screening of older women.
    Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.
    Br J Cancer; 1999 Oct 02; 81(3):554-8. PubMed ID: 10507785
    [Abstract] [Full Text] [Related]

  • 10. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A.
    JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284
    [Abstract] [Full Text] [Related]

  • 11. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 05; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 12. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400
    [Abstract] [Full Text] [Related]

  • 13. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C, Sargent A, Kitchener HC, Peto J.
    Health Technol Assess; 2019 Jun 01; 23(28):1-44. PubMed ID: 31219027
    [Abstract] [Full Text] [Related]

  • 14. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT, Kjaer SK, Munk C, Ørnskov D, Waldstrøm M.
    Acta Obstet Gynecol Scand; 2021 Mar 01; 100(3):394-402. PubMed ID: 33566361
    [Abstract] [Full Text] [Related]

  • 15. Benefits and costs of using HPV testing to screen for cervical cancer.
    Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.
    JAMA; 2002 May 08; 287(18):2372-81. PubMed ID: 11988058
    [Abstract] [Full Text] [Related]

  • 16. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Accetta G, Giordano L, Cogo C, Carozzi F, Gillio Tos A, Arbyn M, Mejier CJ, Snijders PJ, Cuzick J, Giorgi Rossi P.
    Epidemiol Prev; 2012 May 08; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [Abstract] [Full Text] [Related]

  • 17. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
    Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ.
    J Clin Pathol; 2002 Jun 08; 55(6):435-9. PubMed ID: 12037026
    [Abstract] [Full Text] [Related]

  • 18. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.
    Kelly RS, Patnick J, Kitchener HC, Moss SM, NHSCSP HPV Special Interest Group.
    Br J Cancer; 2011 Sep 27; 105(7):983-8. PubMed ID: 21897395
    [Abstract] [Full Text] [Related]

  • 19. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
    Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT.
    JAMA; 2000 Jan 05; 283(1):87-93. PubMed ID: 10632285
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.